Lamotrigine Tablet, Extended Release
Product Images NDC 70518-4702

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Lamotrigine (NDC 70518-4702). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Lamotrigine Extended-release Tablets (11b431ca E7f1 4ef2 B2d6 1be2294d09b2 01)

Chemical structure of lamotrigine showing a triazine ring substituted with amino groups and a dichlorophenyl group.*

FDA Label Image

Lamotrigine Extended-release Tablets (11b431ca E7f1 4ef2 B2d6 1be2294d09b2 02)

A cumulative response rate graph comparing Lamotrigine extended-release tablets to placebo in patients, with percent of patients on the x-axis and weighted response rate on the y-axis. The solid line represents Lamotrigine, showing a higher response over time versus the dashed placebo line.*

FDA Label Image

Lamotrigine Extended-release Tablets (11b431ca E7f1 4ef2 B2d6 1be2294d09b2 03)

A line graph comparing the percentage of patients versus percent improvement in seizure frequency. It contrasts data between placebo (n=120) and Lamotrigine extended-release tablets (n=116), showing relative percent count improvement across the patient population.*

FDA Label Image

Remedy_label (Remedy Label)

Lamotrigine 50 mg extended-release tablets packaging label showing a quantity of 30 tablets. The label features the NDC number 70518-4702-00 and identifies RemedyRepack Inc. as the repackager located in Indiana, PA. Manufacturer details for Zydus Pharmaceuticals, Pennington, NJ, are also included along with storage instructions and safety warnings.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.